IP Library Granted Patent US 6,900,297
Granted Patent B1
US 6,900,297 · App. 08/464,953 · Granted May 31, 2005

Amine-derivatized nucleosides and oligonucleosides

Assignee: ISIS Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,900,297
App. No.
08/464,953
Granted
May 31, 2005
Kind
B1
Abstract

Nucleotides and oligonucleosides functionalized to include alkylamino functionality, and derivatives thereof. In certain embodiments, the compounds of the invention further include steroids, reporter molecules, reporter enzymes, lipophilic molecules, peptides or proteins attached to the nucleotides through the alkylamino group.

Claims (16)

1. A compound which hybridizes with a nucleic acid and comprises a plurality of linked nucleosides, wherein:

each nucleoside includes a pentofuranosyl sugar portion and a base portion; and

at least one of said nucleosides bears at a 2′-O-position, a 3′-O-position, or a 5′-O-position of said pentofuranosyl sugar, a terminal substituent having formula:

—R A —N(R 1a )(R 1b )

where:

R A is alkyl having from 1 to about 10 carbon atoms or (CH 2 —CH 2 —Q) x ;

R 1a and R 1b , independently, are H, R 2 , or an amine protecting group or have formula C(X)—R 2 , C(X)—R A —R 2 , C(X)—Q—R A —R 2 , C(X)—Q—R 2 ; and

R 2 is a peptide;

X is O or S;

each Q is, independently, is NH, O, or S; and

x is 1 to about 200.

2. The compound of claim 1 , wherein more than one of said nucleosides bear said substitution at a 2′-O-position, 3′-O-position, or a 5′-O-position.

3. The compound of claim 1 , wherein R A is (CH 2 ) n where n is an integer from 1 to about 10.

4. The compound of claim 3 , wherein n is 6.

5. The compound of claim 1 , wherein R 1a is H and R 1b is R 2 .

6. The compound of claim 1 , wherein said peptide comprises one or more amino acids.

Assignments (3)
CHANGE OF NAME Recorded Jul 26, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043341/0643 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 1998
From: COOK, PHILLIP DAN; MANOHARAN, MUTHIAH; GUINOSSO, CHARLES J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 008889/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 1996
From: COOK, PHILLIP DAN; MANOHARAN, MUTHIAH
To: ISIS PHARMACEUTICALS, INC
Reel/Frame 007831/0648 →
Continuity (5)
Continuation In Part 0811736300 · Sep 3, 1993
Continuation In Part PCTUS920919600 · Oct 23, 1992
Continuation In Part 0778237400 · Oct 24, 1991
Continuation In Part 0756697700 · Aug 13, 1990
Continuation In Part 0746335800 · Jan 11, 1990